Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial

Uma Ramaswami, Daniel G. Bichet, Lorne A. Clarke, Gabriela Dostalova, Alejandro Fainboim, Andreas Fellgiebel, Cassiano M. Forcelini, Kristina An Haack, Robert J. Hopkin, Michael Mauer, Behzad Najafian, C. Ronald Scott, Suma Shankar, Beth L. Thurberg, Camilla Tøndel, Anna Tylki-Szymanska, Bernard Bénichou, Frits A. Wijburg

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint Dive into the research topics of 'Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds